169447-69-2

Basic information

• Product Name: (S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE
• Synonyms: (S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE;S-1-Boc-2-methyl-4-(phenylmethyl)-piperazine
• CAS NO: 169447-69-2
• Molecular Formula: C₁₇H₂₆N₂O₂
• Molecular Weight: 290.4
• Mol File: 169447-69-2.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE(169447-69-2)
• EPA Substance Registry System: (S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE(169447-69-2)

Safety Data

• Hazardous Substances Data: 169447-69-2(Hazardous Substances Data)

Usage

Description

(S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE is a complex chemical compound belonging to the class of piperazine derivatives. It features a substituted tert-butyl group and a benzyl group attached to the nitrogen atom, along with a methyl group and a carboxylate functional group. (S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE may hold potential in the pharmaceutical industry for the development of novel drugs targeting various medical conditions, although further research is necessary to explore its properties and applications comprehensively.

Uses

Used in Pharmaceutical Industry:
(S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE is used as a chemical intermediate for the synthesis of new pharmaceutical compounds. Its unique molecular structure, which includes a tert-butyl group, a benzyl group, a methyl group, and a carboxylate functional group, may contribute to the development of innovative drugs for various medical conditions.
Used in Drug Development:
In the field of drug development, (S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE serves as a key building block for creating novel drug candidates. Its structural diversity and functional groups can be exploited to design and synthesize potential therapeutic agents with improved pharmacological properties, such as enhanced efficacy, selectivity, and reduced side effects.
Used in Medicinal Chemistry Research:
(S)-TERT-BUTYL 4-BENZYL-2-METHYLPIPERAZINE-1-CARBOXYLATE is utilized as a research tool in medicinal chemistry to study the structure-activity relationships of piperazine-based compounds. Understanding how its molecular features influence biological activity can guide the design of more effective and safer drugs for treating various diseases.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 132871-12-6 (S)-3-Methyl-1-(phenylmethyl)piperazine 
• 118375-95-4 methyl (S)-2-(2-chloroacetamido)propanoate 
• 132871-10-4 (3S)-1-benzyl-3-methylpiperazine-2,5-dione 
• 170033-57-5 (S)-3-Methyl-1-(phenylmethyl)piperazin-2-one 
• 170033-54-2 (S)-<2-<(2-Hydroxyethyl)(phenylmethyl)amino>-1-methyl-2-oxoethyl>carbamic acid 1,1-dimethylethyl ester 
• 104-63-2 N-Benzylethanolamine 
• 7732-18-5 water 
• 1004286-93-4 tert-butyl (S)-4-benzyl-2-methyl-5-oxopiperazine-1-carboxylate 
• 57260-70-5 4-benzyl-piperazine-1-carboxylic acid tert-butyl ester 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 169447-70-5 (S)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity

Neuropeptide S modulates important neurobiological functions including locomotion, anxiety, and drug abuse through interaction with its G protein-coupled receptor known as neuropeptide S receptor (NPSR). NPSR antagonists are potentially useful for the treatment of substance abuse disorders against which there is an urgent need for new effective therapeutic approaches. Potent NPSR antagonists in vitro have been discovered which, however, require further optimization of their in vivo pharmacological profile. This work describes a new series of NPSR antagonists of the oxazolo[3,4-a]pyrazine class. The guanidine derivative 16 exhibited nanomolar activity in vitro and 5-fold improved potency in vivo compared to SHA-68, a reference pharmacological tool in this field. Compound 16 can be considered a new tool for research studies on the translational potential of the NPSergic system. An in-depth molecular modeling investigation was also performed to gain new insights into the observed structure-activity relationships and provide an updated model of ligand/NPSR interactions.

Synthesis of new polysubstituted piperazines and dihydro-2H-pyrazines by selective reduction of 2-oxo-piperazines

New enantiomerically enriched 1,4,5-piperazines and 1,4,5-dihydro-2H-pyrazines have been prepared by reduction of the corresponding 2-oxo-piperazines. Selective reduction can be achieved by careful control of the reaction conditions using LiAlH4/sub

A novel and facile method to synthesize (R)- and (S)-2-methylpiperazine

A concise and efficient synthesis of (R)- and (S)-2-methylpiperazine in only five steps from (D)- and (L)-alanine is described. The key step is reaction of benzylamine with a bifunctional molecule to build a six-membered ring.